CAS 1264-62-6
:Erythromycin ethyl succinate
Description:
Erythromycin ethyl succinate is an antibiotic belonging to the macrolide class, primarily used to treat various bacterial infections. It is a semi-synthetic derivative of erythromycin, which enhances its stability and bioavailability. The compound is characterized by its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making it effective against a range of Gram-positive and some Gram-negative bacteria. Erythromycin ethyl succinate is typically administered orally and is often formulated as a prodrug, which is converted to erythromycin in the body. It is known for its relatively low toxicity and side effects, although gastrointestinal disturbances can occur. The substance is soluble in organic solvents but has limited solubility in water, which influences its formulation and delivery. Additionally, it is important to consider potential drug interactions and resistance patterns when using this antibiotic in clinical settings. Overall, erythromycin ethyl succinate remains a valuable option in the treatment of infections, particularly in patients who are allergic to penicillin.
Formula:C43H75NO16
InChI:InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1
InChI key:InChIKey=NSYZCCDSJNWWJL-YXOIYICCSA-N
SMILES:O(C(CCC(OCC)=O)=O)[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C
Synonyms:- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- EryPed
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
Erythromycin ethyl succinate
CAS:Erythromycin ethyl succinateFormula:C43H75NO16Color and Shape:Off-WhiteMolecular weight:862.0527ERYTHROMYCIN ETHYLSUCCINATE RS
CAS:ERYTHROMYCIN ETHYLSUCCINATE RSFormula:C43H75NO16Molecular weight:862.0527ERYTHROMYCIN ETHYLSUCCINATE CRS
CAS:ERYTHROMYCIN ETHYLSUCCINATE CRSFormula:C43H75NO16Molecular weight:862.0527ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CRS
CAS:ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CRSFormula:C43H75NO16Molecular weight:862.0527Erythromycin Ethylsuccinate
CAS:Erythromycin and its derivatives; salts thereofFormula:C43H75NO16Color and Shape:White PowderMolecular weight:861.50859(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-6-methyloxan-3-yl 1-ethyl butanedioate
CAS:Formula:C43H75NO16Color and Shape:SolidMolecular weight:862.0527Erythromycin ethylsuccinate
CAS:Erythromycin ethylsuccinate (EES) is a macrolide antibiotic, produced by Streptomyces erythreus.Formula:C43H75NO16Purity:77% - 98%Color and Shape:White Or Slightly Yellow Crystalline Powder White To Yellowish Crystalline SolidMolecular weight:862.05Erythromycin Ethylsuccinate
CAS:<p>Erythromycin Ethylsuccinate</p>Purity:≥765IU/mgMolecular weight:862.05g/molErythromycin Ethylsuccinate-13C-d3
CAS:Formula:C4213CH72D3NO16Color and Shape:White To Off-White SolidMolecular weight:866.07Erythromycin Ethylsuccinate
CAS:Formula:C43H75NO16Color and Shape:White To Off-White SolidMolecular weight:862.06Erythromycin-ethyl succinate
CAS:Controlled ProductFormula:C43H75NO16Color and Shape:NeatMolecular weight:862.05Erythromycin Ethyl Succinate
CAS:Controlled Product<p>Applications Erythromycin Ethyl Succinate is a derivative of Erythromycin (E649950), an antibiotic.<br>References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979); Serisier, D. et al.: J. Am. Med. Assoc., 309, 1206 (2013);<br></p>Formula:C43H75NO16Color and Shape:Off-WhiteMolecular weight:862.05Erythromycin Ethyl Succinate-13C,d3
CAS:Controlled Product<p>Applications Erythromycin Ethyl Succinate-13C,d3 is the deuterated form of Erythromycin Ethyl Succinate (E649985), which is a derivative of Erythromycin (E649950), an antibiotic.<br>References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979); Serisier, D. et al.: J. Am. Med. Assoc., 309, 1206 (2013);<br></p>Formula:CC42D3H72NO16Color and Shape:NeatMolecular weight:866.064Erythromycin ethyl succinate
CAS:<p>Erythromycin ethyl succinate is an ester prodrug that is formed by the reaction of erythromycin and ethylsuccinic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. Erythromycin ethyl succinate is also active against Haemophilus influenzae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, Helicobacter pylori, Leptospira interrogans, Bordetella pertussis, Rickettsia rickettsii, Borrelia burgdorferi, Coxiella burnetii, and Mycoplasma pneumoniae. Erythromycin ethyl succinate has been shown to be effective in treating streptococcal pharyngitis and tissue infections.</p>Formula:C43H75NO16Purity:Min. 95%Molecular weight:862.05 g/mol











